Philadelphia Phillies v Atlanta Braves

Today’s decision punishes A-Rod, but it also gives Bud Selig new power

66 Comments

I think the most interesting thing about Alex Rodriguez’s suspension is that curious number of games: 162. It’s such a great number. It matches up so perfectly with a major league baseball season! I thought Ryan Braun’s suspension was interesting too: 65 games. When, as a matter of pure coincidence, I’m sure, the Milwaukee Brewers had 65 games left on their schedule. How neat that is!

It’s almost as if we now have a new matrix for drug suspensions:

  • First offense: 50 games
  • Second offense: 100 games
  • Third offense: lifetime ban
  • Offense by a guy who REALLY makes us look bad and we want to hammer: Until the end of the year, how ever many games that may be.

Which, however satisfying that may be — who doesn’t want A-Rod to just be gone for a season at this point? — is a departure from what Major League Baseball has done with suspensions in the past. Until Braun and now A-Rod, suspensions were for a set number of games, agreed-to beforehand in the Joint Drug Agreement. It was automatic, not a matter of personal judgment by Bud Selig or an arbitrator. We’re in new territory here.

The explanation I’ve seen from some on this — particularly Tom Verducci, but others have said it as well — is that the odd, convenient number of games is because the enforcement action was not based on testing, it was based on non-analytic information (Tony Bosch and the Biogenesis documents) and that when we’re in non-analytic land, the Commissioner has discretion.

Except that is not at all clear from either the terms of the CBA or the JDA. It’s apparently what Bud Selig asserted and, presumably, it’s a position the arbitrator validated in the A-Rod arbitration. But we don’t know, because his decision is sealed. I wonder if, given how much time A-Rod’s lawyers seemed to spend on claiming the existence of a vast conspiracy against their client, they bothered to spend much time arguing that point of the Commissioner’s authority. If they didn’t, that’s pretty awful lawyering.

In any event, that’s basically the effect of this ruling: a big grant of power to Bud Selig to exceed the penalties set forth in the JDA in cases that don’t involve a positive test. A power that, for whatever reason, he decided not to use for Nelson Cruz, Jhonny Peralta and all of the other Biogenesis players, but I suppose that’s convenient too. And, perversely, a power he would not have if the drug testing system he has put in place would have caught these players before we heard about it in the Miami New-Times. Indeed, the failure of the drug testing system worked to Selig’s benefit, which is kind of crazy itself if you think about.

But that’s neither here nor there. The real takeaway here is that Selig now has power in the drug enforcement world he didn’t have before and which he did not obtain via negotiation with the union. He obtained it by simply asserting it and seeing if he could make it stick.  He made it stick.

It’l be interesting to see if the union, under new leader Tony Clark, is going to make this an issue when the new CBA is negotiated or if they’re going to let Selig’s grab for power– his quite successful grab — stand.

The Padres non-tendered RHP Tyson Ross

SAN DIEGO, CALIFORNIA - APRIL 04:  Tyson Ross #38 of the San Diego Padres walks off the field as he's taken out of the game in the sixth inning of a baseball game against the Los Angeles Dodgers on opening day at PETCO Park on April 4, 2016 in San Diego, California.  (Photo by Denis Poroy/Getty Images)
Getty Images
1 Comment

Per a report by MLB.com’s AJ Cassavell, the Padres non-tendered right-handed starter Tyson Ross on Friday, cutting loose their top ace after three seasons with the club.

Ross, 29, was sidelined for the bulk of the season with inflammation in his right shoulder and underwent thoracic outlet surgery in October. His injuries limited him to only 5 1/3 innings in 2016, during which he gave up seven runs and struck out five in a 15-0 blowout against the Dodgers.

Prior to his lengthy stint on the disabled list, the right-hander earned 9.5 fWAR and pitched to a 3.07 ERA and 9.2 K/9 rate in three full seasons with the Padres. He avoided arbitration with a one-year, $9.625 million deal prior to the 2016 season after leading the league with 33 starts and delivering a 3.26 ERA and career-best 4.4 WARP over 196 innings in 2015.

The Padres appear open to bringing Ross back to San Diego, reported Cassavell, albeit not at such a steep cost. Cassavell quoted Padres’ GM A.J. Preller, who was reportedly in trade talks involving Ross but unable to strike a deal, likely due to the right-hander’s recent health issues. Preller denied that those same health issues factored into the club’s decision to non-tender their ace.

With the move, Ross became one of 35 major leaguers to enter free agency on Friday.

Angels’ Pujols has foot surgery, could be sidelined 4 months

pujols
Getty Images
2 Comments

ANAHEIM, Calif. — Los Angeles Angels slugger Albert Pujols had surgery on his right foot Friday, possibly sidelining him past opening day.

Angels general manager Billy Eppler said Pujols had the procedure Friday in North Carolina to release his plantar fascia, the ligament connecting the heel to the toes. The three-time NL MVP was bothered by plantar fasciitis repeatedly during the season, but played through the pain in arguably the strongest year of his half-decade with the Angels.

Eppler said the surgery typically prevents players from participating in baseball activities for three months, along with another month before they’re ready to resume playing in games. Opening day for Los Angeles is April 3, and the Angels hope Pujols can be ready.

“He’s at that point in his career where he’s keenly aware of what’s happening with his body,” Eppler said in a phone interview. “I don’t put the timetable on Albert like you would with your younger players. We’ll just see in Albert’s case, as he progresses, what his timetable is.”

Pujols, who turns 37 next month, batted .268 last year with 31 homers and 119 RBIs, the fourth-most in the majors – although his .780 OPS was among the worst of his career. He largely served as a designated hitter instead of playing first base due to problems with his hamstrings and feet.

Pujols heads into 2017 with 591 career homers, ranking him ninth in major league history. He is 18 homers behind Sammy Sosa for eighth place.

After playing in pain until the final week of the Angels’ disappointing season, Pujols began shock wave therapy on his foot early in the offseason, believing he wouldn’t need surgery.

But Pujols’ foot became more painful in recent weeks despite the therapy, and he huddled with the Angels’ top brass to decide on surgery after his most recent trip to see Dr. Robert Anderson in North Carolina. Continuing with conservative care would have required 10 more weeks, forcing Pujols to miss the first half of the 2017 season if he still required surgery.

“He just felt that the pain had gotten to a point where he was comfortable” having surgery, Eppler said. “If we did delay it, you’re just looking at 2 1/2 more months into the season.”

Pujols had a different type of surgery on his right foot last winter, but recovered in time for opening day. He also had plantar fasciitis in his left foot during the 2013 season, eventually forcing him out for the year when his fascia snapped.

Pujols has five years and $140 million remaining on the 10-year, $240 million free-agent contract that pried him out of St. Louis, where he won two World Series and became a nine-time NL All-Star.

The Angels haven’t won a playoff game since Pujols’ arrival and Mike Trout‘s concurrent emergence as one of baseball’s best players. They went 74-88 last season, the injury-plagued club’s worst record since 1999.